Latest stories on LGVN
Longeveron Inc. (LGVN) files 8-K
SEC 8-K50 · neutralgeneral
Longeveron reports ELPIS II trial misses primary endpoint
The Fly22 · bearishearnings
Longeveron Inc. (LGVN) files 8-K
SEC 8-K50 · neutralgeneral
Longeveron to Participate in Three Longevity/Aging Investment Conferences
GlobeNewswire56 · neutralgeneral
Longeveron to Participate in Three Longevity/Aging Investment Conferences
Business Insider56 · neutralgeneral
Longeveron Inc. (LGVN) files 8-K
SEC 8-K50 · neutralgeneral
Longeveron (LGVN) Heart Treatment Falls Short. Can a Strategic Review Preserve Value?
Yahoo Top28 · bearishproduct/pr
Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial
TipRanks17 · bearishearnings
Longeveron down 55% at $2.98 after resumption of trade
The Fly34 · bearishgeneral
Longeveron exploring all options for maximizing shareholder value
The Fly55 · neutralgeneral
Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial
The Fly28 · bearishproduct/pr
Longeveron to resume trading at 5:55 pm ET
The Fly50 · neutralgeneral
Longeveron Inc trading resumes
The Fly50 · neutralgeneral
Longeveron Inc trading halted, news pending
The Fly48 · neutralgeneral
Longeveron Inc. (LGVN) files 8-K
SEC 8-K50 · neutralgeneral
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan55 · neutralgeneral
Longeveron Inc trading halted, news pending
The Fly48 · neutralgeneral
Longeveron Executes 1-for-10 Reverse Stock Split
TipRanks25 · bearishgeneral
Longeveron plans 1-for-10 reverse stock split to regain Nasdaq minimum bid-price compliance
Seeking Alpha25 · bearishgeneral
Longeveron Inc. (LGVN) files 8-K
SEC 8-K50 · neutralgeneral
Longeveron Announces 1-for-10 Reverse Stock Split
Business Insider25 · bearishgeneral
Longeveron Announces 1-for-10 Reverse Stock Split
GlobeNewswire25 · bearishgeneral